Lang Peter Frederick 4
4 · AERIE PHARMACEUTICALS INC · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Lang Peter Frederick
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2022-11-21$15.25/sh−46,297$706,029→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2022-11-21$6.45/sh−160,551$1,035,554→ 0 totalExercise: $8.80Exp: 2032-03-18→ Common Stock (160,551 underlying)
Footnotes (2)
- [F1]Each of the reported shares of common stock of the Company (each a "Share" or, collectively, the "Shares"), including any Shares of restricted stock, was, at the Effective Time (defined below), cancelled and converted into the right to receive $15.25 in cash (the "Merger Consideration") without interest and subject to any applicable withholding taxes.
- [F2]Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration.